Malignant pleural mesothelioma: Patient selection for pleurectomy

Difficult Decisions in Thoracic Surgery (Second Edition): An Evidence-Based Approach

Volumn , Issue , 2011, Pages 409-415

  Flores, Raja M ^a   Alam, Naveed Z ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84862134246     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-84996-492-0_47     Document Type: Chapter

References (45)

1. Wagner JC, Sleggs CA, Marchand P. Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province. Br J In Med. 1960;17:260-271
2. Verschraegen C. Mesothelioma: Incidence and survival rates in the United States. Proc Am Soc Clin Oncol. 2003;22:869
3. Pass HI, Pogrebeniak HW. Malignant pleural mesothelioma. Curr Probl Surg. 1993;30:921-1012
4. Heelan RT, Rusch VW, Begg CB, Panicek DM, Caravelli JF, Eisen C. Staging of malignant pleural mesothelioma: Comparison of CT and MR imaging. Am J Roentgenol. 1999; 172:1039-1047
5. Benard F, Sterman D, Smith RJ, Kaiser LR, Albelda SM, Alavi A. Metabolic imaging of malignant pleural mesothelioma with fluorodeoxyglucose positron emission tomography. Chest. 1998;114:713-722
6. Flores RM, Akhurst T, Gonen M, Larson SM, Rusch VW. Positron emission tomography defines metastatic disease but not locoregional disease in patients with malignant pleural mesothelioma. J Thor CV Surg. 2003;126:11-15
7. Flores RM, Akhurst T, Gonen M, et al. FDG-PET predicts survival in patients with malignant pleural mesothelioma. Proc Am Soc Clin Oncol. 2003;22:620
8. Schouwink JH, Kool LS, Rutgers EJ, Zoetmulder FA, Van Zandwijk N, v d Vijver MJ, Baas P. The value of chest computed tomography and cervical mediastinoscopy in the preoperative assessment of patients with malignant pleural mesothelioma. Ann Thor Surg. 2003;75:1715-1719
9. Rusch VW, Venkatraman ES. Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically. Ann Thorac Surg. 1999; 68:1799-1804
10. Chahinian AP, Pajak TF, Holland JF, Norton L, Ambinder RM, Mandel EM. Diffuse malignant mesothelioma: Prospective evaluation of 69 patients. Ann Intern Med. 1982;96:746-755
11. Brenner J, Sordillo PP, Magill GB, Golbey RB. Malignant mesothelioma of the pleura: Review of 123 patients. Cancer. 1982;49:2431-2435
12. Law MR, Gregor A, Hodson ME, Bloom HJ, Turner-Warwick M. Malignant mesothelioma of the pleura: A study of 52 treated and 64 untreated patients. Thorax. 1984;39:255-259
13. Chailleux E, Dabouis G, Pioche D, De Lajarte M, De Lajarte AY, Rembeaux A, Germaud P. Prognostic factors in diffuse malignant pleural mesothelioma: A study of 167 patients. Chest. 1988;93:159-162
14. Ruffie P, Feld R, Minkin S, Cormier Y, Boutan-Laroze A, Ginsberg R, Ayoub J, Shepherd FA, Evans WK, Figueredo A, Pater JL, Pringle JF, Kreisman H. Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: A retrospective study of 332 patients. J Clin Oncol. 1989;7:1157-1168
15. Brancatisano RP, Joseph MG, McCaughan BC. Pleurectomy for mesothelioma. Med J Aust. 1991;154: 455-457
16. Rusch VW, Piantadosi S, Holmes EC. The role of extrapleural pneumonectomy in malignant pleural mesothelioma: Lung cancer study group trial. Thorac Cardiovasc Surg. 1991;102:1-9
17. Soysal O, Karaoglanoglu N, Demiracan S, Tupcu S, Tastepe I, Kaya S, Unlu M, Cetin G. Pleurectomy/ decortication for palliation in malignant pleural mesothelioma: Results of surgery. Eur J Cardiothorac Surg. 1997;11:210-213
18. Ceresoli GL, Locati L, Ferreri AJ, Cozzarini C, Passoni P, Melloni G, Zannini P, Bolognesi A, Villa E. Therapeutic outcome according to histologic subtype in 121 patients with malignant pleural mesothelioma. Lung Cancer. 2001;34:279-287
19. Allen KB, Faber LP, Warren WH. Malignant pleural mesothelioma: Extrapleural pneumonectomy and pleurectomy. Chest Surg Clin N Am. 1994;4:113-126
20. Pass HI, Kranda K, Temeck BK, Feuerstein I, Steinberg SM. Surgically debulked malignant pleural mesothelioma: Results and prognostic factors. Ann Surg Oncol. 1997;4:215-222
21. Martin-Ucar AE, Nakas A, Edwards JG, Waller DA. Case-control study between extrapleural pneumonectomy and radical pleurectomy/decortication for pathological N2 malignant pleural mesothelioma. Eur J Cardiothorac Surg. 2007;31:765-770
22. Okada M, Mimura T, Ohbayashi C, Sakuma T, Soejima T, Tsubota N. Radical surgery for malignant pleural mesothelioma: Results and prognosis. Interact Cardiovasc Thorac Surg. 2008;7:102-106
23. Flores RM, Pass HI, Seshan VE, Dycoco J, Zakowski M, Carbone M, Bains MS, Rusch VW. Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: Results in 663 patients. J Thorac Cardiovasc Surg. 2008;135:620-626
24. Luckraz H, Rahman M, Patel N, Szafranek A, Gibbs AR, Butchart EG. Three decades of experience in the surgical multi-modality management of pleural mesothelioma. Eur J Cardiothorac Surg. 2009 Aug 28. [Epub ahead of print
25. Nakas A, Trousse DS, Martin-Ucar AE, Waller DA. Open lung-sparing surgery for malignant pleural mesothelioma: The benefits of a radical approach within multimodality therapy. Eur J Cardiothorac Surg. 2008;34:886-891
26. McCormack PM, Nagasaki F, Hilaris BS, Martini N. Surgical treatment of pleural mesothelioma. Thorac Cardiovasc Surg. 1982;84:834-842
27. Alberts AS, Falkson G, Goedhals L, Vorobiof DA, Van Der Merwe CA. Malignant pleural mesothelioma: A disease unaffected by current therapeutic maneuvers. J Clin Oncol. 1988;6:527-535
28. Mattson K, Holsti LR, Tammilehto L, Maasilta P, Pyrhonen S, Mantyla M, Kajanti M, Salminen US, Rautonen J, Kivisaari L. Multimodality treatment programs for malignant pleural mesothelioma using high-dose hemithorax irradiation. Int J Radiat Oncol Biol Phys. 1992;24:643-650
29. Lee TT, Everett DL, Shu HKFiglin RA, Holmes EC. Radical pleurectomy/decortication and intra-operative radiotherapy followed by conformal radiation with or without chemotherapy for malignant pleural mesothelioma. J Thorac Cardiovasc Surg. 2002;124: 1074-1077
30. Gupta V, Mychalczak B, Krug L, Flores R, Bains M, Rusch VW, Rosenzweig KE. Hemithoracic radiation therapy after pleurectomy/decortication for malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys. 2005;63:1045-1052
31. Lucchi M, Chella A, Melfi F, Dini P, Tibaldi C, Fontanini G, Mussi A. Four-modality therapy in malignant pleural mesothelioma: A phase II study. J Thorac Oncol. 2007;2:237-242
32. Bolukbas S, Manegold C, Eberflein M, Bergmann T, Fisseler-Eckhoff A, Schirren J. Survival after trimodality therapy for malignant pleural mesothelioma: Radical pleurectomy, chemotherapy with cisplatin/ pemetrexed and radiotherapy. Lung Cancer. 2009 Sept 16. [Epub ahead of print
33. Rusch VW, Saltz L, Venkatraman E, Ginsberg R, McCormack P, Burt M, Markman M, Kelsen D. A phase II trial of pleurectomy/decortication followed by intrapleural and systemic chemotherapy for malignant pleural mesothelioma. J Clin Oncol. 1994; 12:1156-1163
34. Rice TW, Adelstein DJ, Kirby TJ, Saltarelli MG, Murthy SR, Van Kirk MA, Wiedemann HP, Weick JK. Aggressive multimodality therapy for malignant pleural mesothelioma. Ann Thor Surg. 1994;58: 24-29
35. Sauter ER, Langer C, Coia LR, Goldberg M, Keller SM. Optimal management of malignant mesothelioma after subtotal pleurectomy: Revisiting the role of intrapleural chemotherapy and postoperative radiation. J Surg Oncol. 1995;60:100-105
36. Lee JD, Perez S, Wang HJ, Figlin RA, Holmes EC. Intrapleural chemotherapy for patients with incompletely resected malignant mesothelioma: The UCLA experience. J Surg Oncol. 1995; 60:262-267
37. Colleoni M, Sartori F, Calabro F, Nelli P, Vicario G, Sgarbossa G, Gaion F, Bartolotti L, Toniolo L, Manente P. Surgery followed by intracavitary plus systemic chemotherapy in malignant pleural mesothelioma. Tumori. 1996;82:53-56
38. Hastürk S, Tastepe I, Unlu M, Cetin G, Baris YI. Combined chemotherapy in pleurectomized malignant pleural mesothelioma patients. J Chemother. 1996;8:159-164
39. Ceresoli GL, Locati L, Ferreri AJ, Cozzarini C, Passoni P, Melloni G, Zannini P, Bolognesi A, Villa E. Therapeutic outcome according to histologic subtype in 121 patients with malignant pleural mesothelioma. Lung Cancer. 2001;34:279-287
40. Sugarbaker D, Richards WG, Zellos LS. Feasibility of pleurectomy and intraoperative bicavitary hyperthermic cisplatin lavage for mesothelioma: A phase I-II study. Proc Am Soc Clin Oncol. 2003;22:620
41. Ratto GB, Civalleri D, Esposito M, Spessa E, Alloisio A, De Cian F, Vannozzi MO. Pleural space perfusion with cisplatin in the multimodality treatment of malignant mesothelioma: A feasibility and pharmacokinetic study. Thorac Cardiovasc Surg. 1999;117: 759-765
42. Pass HI, Temeck BK, Kranda K, Thomas G, Russo A, Smith P, Friauf W, Steinberg SM. Phase III randomized trial of surgery with or without intraoperative photodynamic therapy and postoperative immunochemotherapy for malignant pleural mesothelioma. Ann Surg Oncol. 1997;4:628-633
43. Moskal TL, Dougherty TJ, Urschel JD, Antkowiak JG, Regal AM, Driscoll DR, Takita H. Operation and photodynamic therapy for pleural mesothelioma: 6-year follow-up. Ann Thorac Surg. 1998;66:1128-1133
44. Guyatt G, Gutterman D, Baumann MH, Addrizzo-Harris D, EHylek EM, Phillips B, Raskob G, Lewis SZ and Schünemann H. Grading strength of recommendations and quality of evidence in clinical guidelines. Chest. 2006;129;174-181
45. Van Ruth S, Baas P, Zoetmulder FAN. Surgical treatment of malignant pleural mesothelioma. Chest. 2003;123;551-561